Investors

|

Portal

Order

Search

Patients
EXPLORE PATIENTS
Fight Cancer Smarter
Patient Services
Share Your Story
What is a Biomarker?
Talk to Your Physician
Find a Doctor
Patient Stories
Testing Consent
Financial Services
Pay Your Bill
Fight Cancer Smarter
What is a Biomarker?
Patient Services
Talk to Your Physician
Find a Doctor
Patient Stories
Testing Consent
Financial Services
Pay Your Bill
Share Your Story
Physicians
EXPLORE PHYSICIANS
Physician Tests
Physician Services
TISSUE PROFILING
MI Profile
MI Cancer Seek
MI Tumor Seek Hybrid
BLOOD PROFILING
Caris Assure
AI SIGNATURES
Caris GPSai
Caris FOLFIRSTai
Caris Molecular Tumor Board
Customer Support
Right-In-Time Trials
Physician Tests
TISSUE PROFILING
MI Profile
MI Cancer Seek
MI Tumor Seek Hybrid
BLOOD PROFILING
Caris Assure
AI SIGNATURES
Caris GPSai
Caris FOLFIRSTai
Physician Services
Caris Molecular Tumor Board
Customer Support
Right-In-Time Trials
Biopharma
EXPLORE BIOPHARMA
Core Services
Multimodal Data
Caris Discovery
Molecular Profiling
Clinical Trial Matching
Commercialization
Core Services
Molecular Profiling
Clinical Trial Matching
Commercialization
Multimodal Data
Caris Discovery
Research
EXPLORE RESEARCH
Publications
Artificial Intelligence
Product Pipeline
Manuscripts
Posters
Presentations
Abstracts
Caris CODEai
Nanoverse
Molecular Tumor Board Report
Publications
Manuscripts
Posters
Presentations
Abstracts
Artificial Intelligence
Caris CODEai
Nanoverse
Molecular Tumor Board Report
Product Pipeline
Partners
EXPLORE PARTNERS
Caris POA
EHR Integrations
International Distributors
Members
Working Groups
Fellows Forum
Caris POA
Members
Working Groups
Fellows Forum
EHR Integrations
International Distributors
News & Events
EXPLORE
News
Events
Media Library
Podcasts
Webinars
News
Events
Media Library
Podcasts
Webinars
LATEST NEWS

Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC Patients

April 2026

Caris Life Sciences Announces Launch of Caris ChromoSeq, the World’s First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies

April 2026
About
EXPLORE ABOUT
Careers
Leadership
Locations
Contact Us
Opportunities
Our People
Benefits
Careers
Opportunities
Our People
Benefits
Leadership
Locations
Contact Us